This study aimed to investigate the inhibitory effects of food-derived protein hydrolysates from gliadin, whey, and casein on BACE1 activity and APP metabolism to prevent Aβ aggregation, a critical factor in AD progression. The gene discussed is BACE1; the disease is Alzheimer disease.